Pharming Group N.V. (PHAR) Financials

PHAR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 510.1 million 267.8 million
2023-09-30 462.1 million 239.8 million
2023-06-30 467.3 million 249.5 million
2023-03-31 464.1 million 241.1 million

PHAR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 13.1 million ?
2023-09-30 3.6 million 2.1 million
2023-06-30 -11.3 million 2.6 million
2023-03-31 -25.1 million 1.7 million

PHAR Net Income

No data available :(

PHAR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 235.9 million - -
2023-09-30 209.2 million - 34.4 million
2023-06-30 209.2 million - 37.1 million
2023-03-31 226.0 million - 38.2 million

PHAR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 ?
2023-09-30 71.1 million
2023-06-30 73.1 million
2023-03-31 70.0 million

PHAR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 366393 12.9 million - -
2023-09-30 155620 22.0 million 11.5 million 26.6 million
2023-06-30 838335 22.7 million 11.9 million 36.9 million
2023-03-31 234351 17.0 million 10.9 million 29.5 million

PHAR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 90.5 million 7.9 million
2023-09-30 70.6 million 8.8 million
2023-06-30 59.7 million 6.2 million
2023-03-31 46.4 million 4.4 million

PHAR

Price: $10.45

52 week price:
9.33
16.71

Earnings Per Share: -0.33 USD

P/E Ratio: -40.74

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1500

Market Capitalization: 713.0 million

Average Dividend Frequency: 1

Links: